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Abstract
Background: Diarrhea remains a leading cause of mortality among young children in low- and middle-income countries.
Although the evidence for individual diarrhea prevention and treatment interventions is solid, the effect a comprehensive
scale-up effort would have on diarrhea mortality has not been estimated.
Methods and Findings: We use the Lives Saved Tool (LiST) to estimate the potential lives saved if two scale-up scenarios for
key diarrhea interventions (oral rehydration salts [ORS], zinc, antibiotics for dysentery, rotavirus vaccine, vitamin A
supplementation, basic water, sanitation, hygiene, and breastfeeding) were implemented in the 68 high child mortality
countries. We also conduct a simple costing exercise to estimate cost per capita and total costs for each scale-up scenario.
Under the ambitious (feasible improvement in coverage of all interventions) and universal (assumes near 100% coverage of
all interventions) scale-up scenarios, we demonstrate that diarrhea mortality can be reduced by 78% and 92%, respectively.
With universal coverage nearly 5 million diarrheal deaths could be averted during the 5-year scale-up period for an
additional cost of US$12.5 billion invested across 68 priority countries for individual-level prevention and treatment
interventions, and an additional US$84.8 billion would be required for the addition of all water and sanitation interventions.
Conclusion: Using currently available interventions, we demonstrate that with improved coverage, diarrheal deaths can be
drastically reduced. If delivery strategy bottlenecks can be overcome and the international community can collectively
deliver on the key strategies outlined in these scenarios, we will be one step closer to achieving success for the United
Nations’ Millennium Development Goal 4 (MDG4) by 2015.
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Diarrhea remains a leading cause of morbidity and mortality
among children under 5 y of age in low- and middle-income
countries [1]. Diarrhea mortality has declined from an estimated
4.5 million deaths in the early 1980s to 1.3 million in 2008 with the
advent of oral rehydration salts (ORS), the implementation of
routine vitamin A supplementation and measles vaccine, improved
sanitation, access to clean water, and hand washing, which are
major risk factors for diarrhea incidence in many parts of the
world [1,2]. Given the availability of cost-effective prevention and
treatment interventions, however, the number of deaths owing to
diarrhea remains unacceptably high. Further reduction of diarrhea
mortality is critical if the fourth United Nations’ Millennium
Development Goal (MDG4) —reduction of child mortality by
two-thirds of the 1990 level (12.4 million deaths per year) — is to
be achieved by 2015.
In 2009, UNICEF and WHO published a report on diarrhea
that included a package of key diarrhea prevention and treatment
interventions to reduce diarrhea morbidity and mortality. The
complete package includes improving access to safe water,
community-wide promotion of sanitation, routine rotavirus and
measles immunization, vitamin A supplementation and promotion
of breastfeeding, and treatment with ORS and zinc [3]. Although
the full package of prevention and treatment interventions is based
on solid evidence supporting individual interventions, the effect
that a universal scale-up effort would have on diarrhea mortality
has not been estimated.
The Lives Saved Tool (LiST) is designed to enable international
agencies and country planners to estimate the effect of increasing
coverage of selected intervention combinations, such as the
UNICEF/WHO recommended interventions for diarrhea, on
mortality. LiST utilizes country-specific cause of death profiles and
the effect of selected interventions on cause-specific mortality, and
thus generates country-specific estimates of mortality reductions [4].
Here, we present two scenarios for the scale-up of diarrhea
prevention and treatment interventions from 2010 to 2015. We
use LiST to estimate the potential lives saved if each scale-up
scenario were implemented in the 68 ‘‘Countdown to 2015’’
countries. These 68 countries were prioritized by UNICEF and
partners on the basis of high child mortality rates; together they
represent more than 95% of child deaths [5]. These data are
critical for program planners, funders, and policy and decision
makers to better understand the potential impact on mortality
when investing in diarrhea prevention and treatment at the
country level.
Methods
LiST is a child survival modeling tool that uses country level
under-5 mortality rates and cause of death profiles, and models the
effects of changes in coverage of interventions on overall and
cause-specific mortality rates for children under 5 y of age (http://
www.jhsph.edu/dept/ih/IIP/list/spectrum.html) [4,6]. It is built
into the Spectrum policy modeling system, which includes a
demographic platform based on UN population data, HIV, and
family planning inputs. As a public access tool, analyses such as
these can be performed, repeated, or altered by researchers or
program and policy leaders alike. The effectiveness of each of the
diarrhea interventions incorporated into the LiST tool has been
recently reviewed by the Child Health Epidemiology Reference
Group (CHERG) [7–11] and as part of a universal and published
review [12,13]. The CHERG reviews go beyond previously
published systematic reviews and meta-analyses, utilizing all
available data to provide the best estimate for the effect of each
intervention on diarrhea-specific mortality [6]. In previous
exercises, the LiST tool has estimated mortality reductions due
to coverage changes that have matched well to the measured
changes in mortality [14,15].
Establishing Baseline Values for Cause of Death and
Coverage of Interventions
For this exercise, we generated LiST models for each of the 68
priority countries to project potential reductions in diarrhea
mortality [5]. We used standard country-level child mortality rates
as published by the Interagency Group for Child Mortality
Estimation and the cause of death profiles published by the
CHERG [16,17]. We used baseline intervention coverage values
for improved water supply, household connection, and improved
sanitation from a special analysis of WHO/UNICEF Joint
Monitoring Programme for Water Supply and Sanitation (JMP)
data [18]. For these interventions we assumed no change in
coverage between most recent available data points (typically
2008) and 2010. Vaccination and vitamin A coverage levels were
based on WHO/UNICEF immunization program data [19]. All
other baseline intervention coverage data were based on the most
recent Demographic Health Survey (DHS), Multiple Indicator
Cluster Survey (MICS), or Malaria Indicator Survey (MIS).
Coverage data were not available for selected indicators in Papua
New Guinea and Democratic People’s Republic of Korea; for the
former, we used estimated average regional data for Southeast
Asia for ORS and antibiotic use, and for the latter, estimated data
from China were used for breastfeeding and antibiotic use (see
Table S1 for values).
Ten interventions proven to reduce diarrheal mortality were
modeled. The preventive interventions were breastfeeding, vitamin
A supplementation, hand washing with soap, improved sanitation
(which encompasses toilet facilities and disposal of waste), improved
drinking-water source, treatment of water in the home, and
rotavirus vaccination. The treatment interventions included were
ORS and zinc as well as antibiotics for dysentery. To model
‘‘treatment of water in the home,’’ we assumed a value of 0.21 for
the effect of this indicator on diarrhea incidence and mortality [20].
Current coverage of this indicator is not available for all countries
and it would be inappropriate to assume that 100% of households
currently need clean water.We used the percentofchildren livingin
households with piped water as a proxy for current coverage of a
clean water supply, available for all countries from the JMP [18].
This is likely to generate a conservative estimate of the potential
impact of treatment of water, as it is probable that some households
with piped water also need treatment. We included antibiotics for
dysentery, though this was not included in the recent UNICEF/
WHOrecommended package,because itremainsan important tool
for treating dysenteric diarrhea. Lastly, measles vaccination, which
is included in the UNICEF/WHO recommended package, was not
included because measles-related diarrheal deaths are attributed to
measles directly. Baseline values are presented in Table 1 for all
interventions except breastfeeding. Additional details with regard to
assumptions about breastfeeding coverage can be found in Table
S1.
Modeling Increased Coverage of Interventions
Within the model, all chosen interventions have a direct impact
on diarrheal mortality reduction. Four of the seven interven-
tions—improved water source, treatment of water in the home,
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Country
Percentage of Children ,5y
with Access to/Practicing
Percentage of Children
with Diarrhea in Last 2 wk Who
Were Treated
Percentage of Children
Who Received
Improved
Water
a
Treated
Water
b
Improved
Sanitation
a
Hand-
Washing
c ORS
d
Antibiotics
for
Dysentery
e
Zinc for
Diarrhea
Treatment
f
Rotavirus
Vaccination
g
Vitamin A
Supplementation
h
Afghanistan 48 4 37 17 30 16 0 0 96
Angola 50 20 57 17 40 20 0 0 82
Azerbaijan 80 50 45 17 10 5 0 0 90
Bangladesh 80 6 51 17 77 22 23 0 97
Benin 75 12 12 17 23 12 0 0 52
Bolivia 86 77 25 17 29 31 0 0 45
Botswana 95 62 60 17 49 24 0 0 15
Brazil 97 91 80 17 56 25 0 71 0
Burkina Faso 76 4 11 17 17 31 0 0 100
Burundi 72 6 46 17 38 26 0 0 80
Cambodia 61 16 29 17 21 12 0 0 88
Cameroon 74 15 47 17 13 38 0 0 92
CAR 67 2 34 17 17 39 0 0 68
C h a d 5 059 1 71 5 1 2 0 0 0
China 89 83 55 13 29 33 0 0 0
Congo 71 28 30 17 18 22 0 0 10
Cote d’Ivoire 80 40 23 17 14 19 0 0 90
Djibouti 92 72 56 17 49 43 0 0 86
Democratic
People’s
Republic
of Korea
100 77 59 17 35 33 0 0 85
Democratic
Republic
of the
Congo
4 6 9 2 31 7 3 1 2 10 0 9 8
Egypt 99 92 94 17 34 73 1 0 68
Equatorial Guinea 43 6 51 17 36 18 0 0 0
Eritrea 61 9 14 17 45 22 0 0 49
Ethiopia 38 7 12 17 20 5 0 0 88
Gabon 87 43 33 17 25 24 0 0 0
Gambia 92 33 67 17 41 61 0 0 28
Ghana 82 17 13 3 45 33 0 0 24
Guatemala 94 81 81 17 30 15 0 0 20
Guinea 71 10 19 17 33 17 0 0 94
Guinea-Bissau 61 9 21 17 26 42 0 0 66
Haiti 63 12 17 17 40 5 0 0 34
I n d i a 8 82 2 3 1 4 22 6 1 3 0 0 5 3
Indonesia 80 23 52 17 35 33 0 0 86
Iraq 79 76 73 17 31 82 0 0 0
Kenya 59 19 31 17 29 22 0 0 27
L a o s 5 72 0 5 3 1 73 1 5 2 0 0 6 9
Lesotho 85 19 12 17 42 27 0 0 38
Liberia 68 2 17 17 53 49 0 0 85
Madagascar 41 7 11 4 12 20 0 0 97
Malawi 80 7 56 17 63 30 0 0 95
Mali 56 12 36 17 14 7 0 0 97
Mauritania 49 22 26 17 22 24 0 0 87
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indirect impact on multiple causes of mortality via a reduction in
the rate of stunting. LiST applies the documented effectiveness for
each intervention to the total diarrheal deaths possible among
children under 5 for each given year. For each intervention the
effectiveness value is applied to the residual number of diarrheal
deaths available to ‘‘save’’ for that year thus eliminating the
potential to double count lives saved.
The scale-up scenarios presented here assume a linear increase
in coverage from the baseline coverage year, 2010 (using the most
recent data available) through the year 2015; this allowed us to
generate the total number of diarrheal deaths, by country for each
year between 2010 and 2015. For an estimate of baseline diarrheal
deaths we applied the 2008 overall mortality rate and the cause of
death structure to the 2010 population.
We applied two different scale-up scenarios of the seven
diarrhea prevention and three treatment interventions, repre-
senting ambitious but feasible coverage objectives and a universal
coverage plan. The first or ‘‘ambitious’’ scenario represents what
is felt to be an essential and realizable scale-up strategy as
countries strive to reduce under-five mortality in the context of
achievement of MDG4, whereas the second or ‘‘universal’’
scenario represents maximum levels that could be achieved
through an aggressive, highly concerted, and better-funded
Country
Percentage of Children ,5y
with Access to/Practicing
Percentage of Children
with Diarrhea in Last 2 wk Who
Were Treated
Percentage of Children
Who Received
Improved
Water
a
Treated
Water
b
Improved
Sanitation
a
Hand-
Washing
c ORS
d
Antibiotics
for
Dysentery
e
Zinc for
Diarrhea
Treatment
f
Rotavirus
Vaccination
g
Vitamin A
Supplementation
h
Mexico 94 87 85 17 4 15 0 0 63
Morocco 81 58 69 17 23 17 0 0 43
Mozambique 47 8 17 17 49 15 0 0 83
Myanmar 71 6 81 17 45 18 0 0 94
Nepal 92 19 32 17 29 25 0 0 93
Niger 48 7 9 17 18 9 0 0 92
Nigeria 58 6 32 17 18 46 0 0 74
Pakistan 90 33 45 17 41 50 0 0 97
Peru 82 70 68 14 28 28 0 0 0
Philippines 91 48 76 17 42 36 0 0 86
Papua New Guinea 40 10 45 17 30 30 0 0 7
Rwanda 65 4 54 17 21 13 0 0 76
Senegal 69 38 51 23 15 20 0 0 90
Sierra Leone 49 6 13 17 52 45 0 0 12
Somalia 30 19 23 17 9 32 0 0 100
South Africa 91 67 77 17 40 32 0 0 39
S u d a n 5 72 8 3 4 1 75 8 4 5 0 0 6 7
Swaziland 69 32 55 17 86 24 0 0 44
Tajikistan 70 40 94 17 48 41 0 0 na
Tanzania 54 8 24 13 54 22 0 0 93
Togo 60 6 12 17 11 26 0 0 64
Turkmenistan 71 45 95 17 47 50 0 0 0
Uganda 64 3 47 14 40 47 0 0 67
Yemen 62 28 52 17 33 38 0 0 47
Zambia 60 14 49 17 60 14 0 0 96
Zimbabwe 82 36 44 17 6 8 0 0 20
aData from JMP 2010.
bUsed piped water values from the JMP 2010 report.
cEstimates based on work Curtis et al. [31].
dMost recent Demographic Health Survey (DHS)/Multiple Indicator Cluster Survey (MICS). Defined as percent of children with diarrhea in the past 2 wk who were
treated with ORS or prepackaged ORS solutions.
eMost recent DHS/MICS. Assumed to be the same as percent of children with symptoms suggestive of pneumonia treated with an antibiotic.
fMost recent DHS/MICS. Defined as percent of children with diarrhea in the past 2 wk treated with zinc. If these data were not collected in the survey, 0 was the default
value.
gEstimates from WHO/UNICEF estimates of national immunization coverage [32].
hUNICEF 2008 value or most recent. Countries listed as na are considered not to be Vitamin A deficient according to the Lancet Nutrition series and were excluded from
the analysis.
doi:10.1371/journal.pmed.1000428.t001
Table 1. Cont.
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representing the ambitious and universal scale-up scenarios. For
breastfeeding, coverage estimates vary by age group (,1 mo, 1–
5 mo, 6–11 mo, 12–23 mo) and degree of exclusivity (exclusive,
predominant, partial, none). For any country that has already
attained themodeled levelofcoverage fora specificintervention,we
assumed maintenance of the achieved coverage rate. Additional
details on individual country calculations can be found in Table S1.
Estimating the Cost of Scale-up
We conducted a cost analysis for the specified interventions in
both scale-up scenarios using an ingredients-based approach.
For preventive interventions the population in need was defined
as the number of children under 5 (vitamin A, rotavirus
vaccine, breastfeeding) or, for the water, sanitation, and hygiene
(WASH) interventions, the households with children under 5 y. For
the treatment interventions we assumed that all cases would receive
ORS and zinc; we also estimated the proportion of episodes that
wouldmeetthe clinicaldefinitionofdysenteryand requireantibiotic
treatment. Drug, supply and personnel time requirements per
average case were calculated based on WHO treatment guidelines
and expert opinion, and then costed using UNICEF’s supply
catalogue [21] and WHO CHOICE’s country-specific database of
medical staff salaries [22]. We also included costs of outreach
activities and communication strategies. For non-WASH interven-
tions, the analysis looked only at direct costs of providing the
interventions; costs associated with capital investments such as
building new health centers and training facilities are not captured
in this analysis. We calculated the costs for the continuation of
baseline coverage rates and the scale-up of both scenarios for all 68
countries included in this model. We then calculated the total per
capita (total population) cost as well as the additional per capita cost
Table 2. Modeled target coverage rates by intervention for two scale-up plans for the 68 priority countries.
Intervention
a
LiST Estimates of Effectiveness
of Diarrheal Deaths Averted
Percent National Target Coverage among
Children ,5 y of Age by 2015
Ambitious Coverage Universal Coverage
ORS for treatment of all episodes 93%
b 75 90
Zinc (10–14 d of supplementation) for
treatment of all episodes
23% 50 90
Antibiotics for dysentery episodes 99%
c 75 90
Rotavirus vaccine 74%
d 50 90
Routine vitamin A supplementation
for children 6–59 mo (twice yearly)
32% 90 90
Hand-washing with soap 48% 35 55
Improved sanitation (primarily toilet construction) 69% 67 75
Access to safe water (improving water quality
at source and safe storage in home) [18]
17% — 99
Africa — 75 —
Asia — 86 —
Home purification of water 21% 30 70
Breastfeeding: RR of diarrhea mortality
Exclusive breastfeeding (no additional fluids or foods)
0–5 mo 1.0 70 90
6–23 mo 1.0 — —
Predominant breastfeeding (breastfeeding with
only additional water and water based fluids)
0–5 mo 2.28 10 5
6–23 mo 1.0 0 0
Partial breastfeeding (breastfeeding
with additional fluids and/or foods)
0–5 mo 4.62 10 0
6–11 mo — 90 95
6–23 mo 1.0 — —
12–23 mo — 75 85
No breastfeeding
0–5 mo 10.53 — —
6–23 mo 2.28 — —
aAll interventions are applied to the 1–59 mo age group except ORS, which is applied to 0–59 mo and vitamin A, which is applied to 6–59 mo.
bApplied to nondysentery diarrheal deaths assumed to be 95% of total diarrheal deaths.
cApplied to dysentery diarrheal deaths assumed to be 5% of total diarrheal deaths.
dApplied to rotavirus deaths assumed to be 39% of total diarrheal deaths.
RR, relative risk.
doi:10.1371/journal.pmed.1000428.t002
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Costs for the WASH interventions were kept separate from the
individual-level prevention and treatment interventions.
Results
Figure 1 presents trends in the number of diarrheal deaths
between 2010 and 2015 for each of the two scenarios; it also shows
the proportion of diarrheal deaths that would occur each year
relative to the 2010 baseline values. Under the ambitious scenario,
the number of diarrheal deaths would decline from more than
1.39 million a year in the baseline year of 2010 to 334,000 in 2015,
which represents a 78% decline and nearly 1 million deaths
averted in 2015. Over the 5-y scale-up period, more than 3.8
million deaths would be averted. Assuming linear scale-up, the
estimated additional cost to achieve this reduction is US$0.49 per
capita in 2015 for the non-WASH interventions and an additional
US$1.78 per capita if 100% of the cost of the WASH interventions
was to be borne by the public health system (Table 3). The total
additional cost for scaling up all non-WASH interventions as per
the ambitious scenario in these 68 countries over a 5-y period is
US$7.7 billion. If WASH interventions were to be included the
costs would rise to US$49.2 billion.
With the universal coverage scenario, the number of diarrheal
deaths would drop to less than 115,000 in 2015, more than a 92%
decline from the 2010 levels, representing nearly 1.4 million deaths
averted in 2015 (Figures 1 and 2) and more than 4.9 million deaths
during the 5-y scale-up period. To achieve these coverage rates,
we estimate an additional cost of US$0.80 per capita in 2015 and
an additional US$3.24 per capita with the addition of all WASH
interventions at the highest coverage rates and all costs borne by
the health system (Table 2). The total additional cost for scaling up
all non-WASH interventions, as per the universal scenario in the
68 countries included in these analyses over a 5-y period, is
US$12.5 billion. If WASH interventions are also included the costs
rise to US$84.8 billion. Under both scenarios, 51% of deaths
averted would be in just five countries: India, Nigeria, Democratic
Republic of the Congo, Pakistan, and Afghanistan, that is 700,000
and 900,000 deaths in 2015 in the ambitious and universal scale-
up scenarios, respectively.
Discussion
In this exercise we used LiST to simulate the potential lives that
could be saved by scaling-up ten simple and effective interventions
for the prevention and treatment of diarrhea in 68 priority
countries. The results of this modeling exercise demonstrate that
with currently available technology, diarrheal deaths could be
reduced by at least 78% by the end of 2015. To reach MDG4 by
2015, the number of child deaths needs to be reduced by an
additional 4.6 million annually from the 2008 estimate of 8.8
million. Reducing diarrheal deaths by more than 1.4 million per
year would be a major contribution toward this goal.
By using LiST to model the impact of scaling up multiple
interventions we are able to illustrate the potential benefits of two
scale-up scenarios over a 5-y period. LiST is a useful tool for
modeling the effect of multiple prevention and treatment
interventions because the effect of each intervention is applied
step-wise in a cohort model. With this type of model, the effect of a
second intervention is only observed on the residual of the first
intervention. This ensures that potential lives are not saved more
than once thus eliminating the risk of double counting. While
coverage for many interventions, such as ORS, is routinely
collected in most countries, coverage data for water and sanitation
interventions that truly reflect optimal practices are extremely
limited and in the case of home purification of water, completely
Figure 1. Trends in number and proportion of diarrheal deaths, under ambitious and universal scale-up plans.
doi:10.1371/journal.pmed.1000428.g001
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Year
Baseline Cost Per
Capita (US$)
a Additional Cost Per Capita (US$)
Ambitious Scale-Up Universal Scale-Up
All Interventions
Excluding WASH
b
WASH Interventions
Alone
c
All Interventions
Excluding WASH
b
WASH Interventions
Alone
c
2011 2.77 0.11 1.38 0.17 2.43
2012 2.71 0.21 1.58 0.33 2.63
2013 2.68 0.30 1.68 0.49 2.86
2014 2.63 0.40 1.75 0.65 3.04
2015 2.57 0.49 1.78 0.80 3.24
2011–2015 NA 1.52 8.18 2.47 14.23
aAssumes maintaining 2010 coverage levels through 2015.
bInterventions include vitamin A, rotavirus vaccine, and breastfeeding for prevention and ORS, zinc, and antibiotics for dysentery for treatment of diarrhea.
cInterventions include hand-washing, improved sanitation, access to safe water, and home purification of water.
NA, not available.
doi:10.1371/journal.pmed.1000428.t003
Figure 2. Number of child deaths averted in 2015 under the universal scale-up program for the 68 countries included in the
analysis.
doi:10.1371/journal.pmed.1000428.g002
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estimates generated by LiST will continue to improve.
In this exercise we did not account for the fact that a proportion
ofchildrenwill haveaccesstoallinterventions, whileaproportion of
children representingthose hardest to reach will likely receive few, if
any, of the interventions [23]. The LiST tool assumes linearity
between coverage of the intervention and the lives saved. Though
we recognize that this may not be an accurate portrayal of what
happens as coverage increases within a community, we do not
currently have the evidence to support an alternative such as a
threshold effect, minimum coverage, or herd immunity for these
interventions. Ensuring that these lifesaving diarrhea prevention
and treatment interventions reach the poorest and most vulnerable
populations will be crucial for achievement of equity and maximum
impact when scaling up programs if the predicted mortality
reductions are to be achieved. For this model, the baseline scenario
assumes current coverage values would remain the same through
2015 and thus diarrhea mortality rates would also remain constant.
We recognize that there might be some small change in diarrhea
mortality as a result of improved economic conditions, and other
factors within a community which could also impact diarrhea
mortality and are not captured here, but we believe these changes
would be relatively small over the short time period captured in this
exercise. This limitation could thus be more problematic over a
longer time period where the magnitude of these societal changes
could be expected to be much greater.
In this analysis, we estimated the cost of scaling up selected
interventions in 68 countries. At an additional cost of US$0.80 per
person per year, we can achieve nearly universal coverage of many
key diarrhea prevention and treatment interventions. With
additional investments in water and sanitation by households
and the public sector we could ensure nearly every young child has
access to safe water. We did not calculate costs per life saved
because this analysis presents only the diarrheal deaths averted
and thus fails to capture the full impact. Many of the diarrhea
interventions avert deaths from other causes, either directly though
prevention of pneumonia (e.g. breastfeeding) or indirectly via a
reduction in diarrhea incidence (e.g. hygiene promotion) and
stunting and thus the diarrheal deaths averted, which are
presented here, likely underestimate the total deaths averted when
scaling up this package of interventions.
It was beyond the scope of this analysis and costing exercise to
fully estimate the costs required to adequately strengthen the
health system in 68 diverse countries to sustainably maintain these
high coverage levels. Furthermore, evidence suggests that cost
curves are complex and nonlinear for infrastructure, commodities
management, transportation, performance monitoring, and su-
pervision [24]. We recognize that ensuring coverage in geograph-
ically or socially underserved communities may require strategies
or delivery channels that are more costly than those needed to
reach more accessible populations and, thus, generalizing per
capita expenses where both disease burden and access to the
health system vary has its limitations [25,26]. Additional studies to
explore variations in costing strategies are needed and may
produce results that are more tailored to specific countries and
populations.
To ensure the high coverage rates proposed here are achievable,
new resources are needed to strengthen health systems for delivery
of services, and to support the introduction and scale-up of
recently introduced interventions for diarrhea treatment (low
osmolarity ORS and zinc) and prevention (rotavirus vaccine) [27].
It is recognized that intense promotion of ORS use at the
community level, and training of health workers during the WHO
program for the control of diarrheal disease in the 1980s, was
successful in scaling up coverage and reducing diarrheal deaths,
although progress stagnated during the 1990s [3,28]. There is
evidence that promotion of zinc for diarrhea treatment alongside
ORS can increase uptake and use, reduce unnecessary antibiotic
use, and reinvigorate community management of diarrhea
[29,30]. However, there are a number of potential obstacles
related to financing, national policy formulation, training, service
delivery, and demand creation that are currently limiting scale-up
of these strategies and that require urgent attention.
Real progress can be made if the prevention and treatment of
diarrhea becomes an international priority and the global health
community commits to a number of key actions as laid out in the
2009 UNICEF and WHO report [3]: mobilizing dedicated and
sufficient funding for diarrhea control; leveraging global partner-
ships and networks for strong and effective advocacy; establishing
clear and targeted health promotion and behavior change
communication strategies; expanding the reach of health services
into communities to ensure that diarrhea prevention and
treatment is a central component of a ‘‘revitalized’’ community-
based primary health care approach; and undertaking comple-
mentary efforts across both public and private sectors to promote
innovations in supply and delivery of these key interventions to
reach high and equitable coverage. In addition, because increasing
coverage of these interventions requires input and leadership from
multiple sectors and ministries within government, coordination
will be critical to ensure success. lf the bottlenecks can be
overcome and the international community can collectively deliver
on the key actions noted above, then child morbidity and mortality
due to diarrhea can be dramatically reduced and contribute to the
achievement of MDG4. These analyses remind us that reaching
goals in reducing under-five mortality does not require the
development of new technologies or interventions; rather, these
can be reached by implementing existing low cost and effective
interventions.
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Background. Diarrhea—passing three or more loose or
liquid stools per day—kills about 1.5 million young children
every year, mainly in low- and middle-income countries. It is
the second leading cause of death in under-5-year olds and
causes nearly one in five child deaths. Diarrhea, which can
lead to life-threatening dehydration, is a common symptom
of gastrointestinal infections. The viruses, bacteria and
parasites that cause diarrhea spread through contaminated
food or drinking water, and from person-to-person through
poor hygiene and inadequate sanitation (unsafe disposal of
human excreta). Interventions that prevent diarrhea include
improvements in water supplies, sanitation and hygiene, the
promotion of breastfeeding, vitamin A supplementation, and
vaccination against rotavirus (a major cause of diarrhea).
Treatments for diarrhea include oral rehydration salts (ORS),
which prevent and treat dehydration, and zinc
supplementation, which decreases the severity and
duration of diarrhea, and antibiotics for dysentery.
Why Was This Study Done? Deaths from diarrhea in
young children have declined markedly over the past 30
years. However, if diarrhea deaths are not reduced further, it
is unlikely that Millennium Development Goal 4 (MDG4; one
of the goals agreed by world leaders in 2000 to reduce
poverty)—the reduction of child mortality by two-thirds of
the 1990 level by 2015—will be reached. In 2009, UNICEF
and the World Health Organization (WHO) proposed a new
diarrhea reduction plan. Although the effect of individual
interventions in this plan is established, the likely effect of
the whole package on diarrhea mortality has not been
estimated. Such information would be useful for health
policy planning. In this study, the researchers use the Lives
Saved Tool (LiST) to estimate the potential lives saved by
scale-up of diarrhea prevention and treatment interventions
in 68 high child mortality countries that together account for
95% of child deaths. LiST is a child survival modeling tool
that uses country-level under-5 death rates and cause of
death profiles to model the effects of changes in health
intervention package coverage on deaths among children.
What Did the Researchers Do and Find? The researchers
calculated 2010 (baseline) coverage values for seven
prevention interventions (breastfeeding, vitamin A
supplementation, hand washing with soap, improved
sanitation, improved water source, better household water
treatment, and rotavirus vaccination) and for three treatment
interventions (ORS, zinc supplementation, and antibiotics for
dysentery) from published data. They then used LiST to
estimate the effect on diarrhea deaths of scaling up
intervention coverage according to two scenarios. The
‘‘ambitious’’ scenario assumed a feasible increase in the
coverage of all interventions from the baseline year to 2015
in 68 countries with high child mortality. The ‘‘universal’’
scenario assumed an increase to near 100% coverage for all
the interventions. Diarrhea mortality was reduced by 78%
and 92% by 2015 under the ambitious and universal
scenarios, respectively. Over the 5 years of the scale-up,
the universal scenario averted nearly 5 million deaths. The
researchers also estimated that the additional costs in 2015
of personal prevention and treatment interventions would
be US$0.80 per capita with universal coverage; the additional
costs for these interventions and all sanitation and water
interventions would be US$3.24 per capita.
What Do These Findings Mean? These findings suggest
that, with currently available interventions, it should be
possible to reduce diarrhea deaths substantially at a
reasonable cost. As with all computer models, the accuracy
of these findings depends on the data and assumptions fed
into the model, which does not, for example, account for the
difficulties that may be encountered in scaling up
intervention coverage in hard to reach populations.
Similarly, the estimated costs associated with the two
scenarios do not include the resources required to
strengthen health systems in developing countries so that
they are able to sustain high coverage levels of diarrhea
prevention and treatment interventions. Nevertheless, these
findings suggest that child mortality due to diarrhea could
be significantly reduced by 2015 provided the international
community acts collectively to deliver these interventions.
Most importantly, the potential 1.4 million lives saved in that
year would bring MDG4 a step closer simply by
implementing existing low cost and effective interventions.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000428.
N The World Health Organization provides information on
diarrhea (in several languages); its 2009 report with UNICEF
‘‘Diarrhea: why children are still dying and what can be
done’’, which includes the WHO/UNICEF treatment and
prevention plan, can be downloaded from the Internet
N The children’s charity UNICEF, which protects the rights of
children and young people around the world, provides
information on water, sanitation, and hygiene, and on
diarrhea (in several languages)
N The United Nations Millennium Development Goals
provides information on ongoing world efforts to reduce
child mortality
N More details on LiST are available
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